Public Media Works Inc. (PUBQQ) Financials Oct 21, 2014,

New Post Public Reply Private Reply Replies (0) Message Board
Hirata
Public Media Works Inc. (PUBQQ) Financials Oct 21, 2014, 7:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Public Media Works Inc.


Fiscal year is March-February. All values USD millions. 2008 2009 2010 2011 2012 5-year trend
Sales/Revenue 0 0 50,000 7,139 39,116
Cost of Goods Sold (COGS) incl. D&A 4,770 2,000 279 12,265 218,600
COGS excluding D&A 1,159 0 0 7,077 59,053
Depreciation & Amortization Expense 3,611 2,000 279 5,188 159,547
Depreciation 3,611 2,000 279 5,188 48,996
Amortization of Intangibles - - - - 110,551
Gross Income (4,770) (2,000) 49,721 (5,126) (179,484)
2008 2009 2010 2011 2012 5-year trend
SG&A Expense 325,726 196,780 24,661 6.83M 4.49M
Research & Development - - 0 0 0
Other SG&A 325,726 196,780 24,661 6.83M 4.49M
Other Operating Expense 0 109,945 78,159 733,090 0
Unusual Expense 294,743 66,550 25,000 0 1.85M
EBIT after Unusual Expense (294,743) (66,550) (25,000) 0 (1.85M)
Non Operating Income/Expense 0 0 0 (23,706) (74,918)
Non-Operating Interest Income 0 0 0 0 0
Equity in Affiliates (Pretax) (2,215) (1,414) 0 0 0
Interest Expense 69,664 54,978 58,036 85,662 52,487
Gross Interest Expense 69,664 54,978 58,036 85,662 52,487
Interest Capitalized 0 0 0 - 0
Pretax Income (697,118) (431,667) (136,135) (7.68M) (6.65M)
Income Tax 1,600 1,178 0 0 0
Income Tax - Current Domestic 1,600 1,178 0 0 0
Income Tax - Current Foreign 0 0 0 0 0
Income Tax - Deferred Domestic 0 0 0 0 0
Income Tax - Deferred Foreign 0 0 0 0 0
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (698,718) (432,845) (136,135) (7.68M) (6.65M)
Minority Interest Expense 0 0 0 0 0
Net Income (698,718) (432,845) (136,135) (7.68M) (6.65M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (698,718) (432,845) (136,135) (7.68M) (6.65M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (698,718) (432,845) (136,135) (7.68M) (6.65M)
EPS (Basic) (0.26) (0.09) (0.03) (0.36) (0.17)
Basic Shares Outstanding 2.71M 5.04M 5.35M 21.59M 38.91M
EPS (Diluted) (0.26) (0.09) (0.03) (0.36) (0.17)
Diluted Shares Outstanding 2.71M 5.04M 5.35M 21.59M 38.91M
EBITDA (326,885) (306,725) (52,820) (7.56M) (4.51M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Discovering Innovation: Smitty's Car Wash on Public Television

Updated Category News Views 332

Innovation at Smitty's Car Wash Viewers are in for an enlightening experience as the show "Empowered with Meg Ryan" spotlights Smitty's Car Wash, a pioneer in the express tunnel car wash industry. This segment promises to challenge traditional notions of car washing, showcasing how modern methods and technology integrate to create not just services, but transformative...

Continue Reading
ASPCA® Expands Veterinary Services with New Clinic Opening

Updated Category News Views 144

ASPCA® Opens New Community Veterinary Clinic in New York The ASPCA Community Veterinary Clinic, supported by The Rachael Ray Foundation, is set to meet the needs of many pets in the local area. This opening in New York City is a crucial advancement in providing vital veterinary care to communities in need. Veterinary Services That Are Within Reach Thousands of pets in...

Continue Reading
Big Boost for European Innovation with Novo Nordisk Foundation's Grant

Updated Category News Views 91

Novo Nordisk Foundation Boosts Innovation Funding In a groundbreaking move to enhance innovation in Europe, the Novo Nordisk Foundation is investing up to DKK 5.5 billion (approximately EUR 736 million) into the BioInnovation Institute (BII). This funding is set to play a transformative role in supporting entrepreneurs and startups within the life sciences sector....

Continue Reading
Legal Challenges for 3D Systems: Investor Action Recommended

Updated Category News Views 165

Overview of the Legal Situation Recent events surrounding 3D Systems Corporation have raised significant concerns among investors. The company is currently facing a class action lawsuit that alleges violations of securities laws. Investors in 3D Systems are encouraged to stay informed about the progress of this legal challenge and consider their options moving forward....

Continue Reading
Inhibikase Therapeutics Updates: Q2 2025 Financial Overview

Updated Category News Views 135

Inhibikase Therapeutics Q2 2025 Financial Update Inhibikase Therapeutics, Inc. (NASDAQ: IKT) is making notable strides as a clinical-stage pharmaceutical company dedicated to developing innovative therapeutics aimed at addressing cardiopulmonary diseases, particularly Pulmonary Arterial Hypertension (PAH). Recently, they announced their financial results for the second...

Continue Reading